Revolutionary Cochlear Implant Technology Debuts in Switzerland After U.S. Success

iotaMotion Expands Cochlear Implant Technology Globally

In an exciting development for auditory technology, iotaMotion, Inc. has successfully introduced its innovative iotaSOFT® insertion system outside the United States. This landmark moment took place at the University Hospital of Zurich, Switzerland, under the guidance of Professor Alexander Huber. The system, recognized as a leader in robotic-assisted cochlear implant surgery, is now at the forefront of clinical research intended to optimize patient outcomes in hearing solutions.

The clinical study, titled "Electrococheographic Signal Analysis During Electrode Guide Insertion in Cochlear Implants with Speed Control in a Non-randomized Controlled Trial," signifies a pivotal moment in both the history of iotaMotion and the cochlear implant market as a whole. With over 750 cases successfully utilizing the iotaSOFT system in the United States, the technology offers unprecedented control over electrode guide insertion, displaying remarkable precision which enhances intracochlear recordings through real-time electrococheography (ECochG).

Professor Huber emphasized the significance of this collaboration, stating, "Bringing this robotic-assisted technology to the University of Zurich is crucial for our team. It allows us to further advance cochlear implant care and explore techniques that have never been clinically utilized before."

This study harnesses the robotic control of the electrode matrix insertion to investigate the relationship between the dynamics of electrode insertion and cochlear function, as measured by ECochG signals. Such an approach could potentially pave the way for future innovations in cochlear implant programming and hearing preservation strategies.

Mike Lobinsky, the CEO and General Manager of iotaMotion, expressed his enthusiasm for this international expansion: "This marks an important milestone for iotaMotion as we extend our technology beyond the borders of the United States. The Zurich team has been an exceptional partner, and we look forward to continuing this relationship."

While still in the pre-commercial clinical investigation phase, the iotaSOFT insertion system is expected to be widely available by 2026. This timeline reflects iotaMotion's commitment to advancing auditory health technologies and improving patient experiences and outcomes.

About iotaMotion

Founded in St. Paul, Minnesota, iotaMotion, Inc. focuses on enhancing cochlear implant surgery with advanced robotic-assisted solutions. The flagship iotaSOFT® System aims to deliver slow, consistent insertion of the electrode guide, crucial for preserving delicate intracochlear structures. Currently available for use in the United States, iotaSOFT is in clinical research phases across various international markets.

For more information, visit www.iotamotion.com or contact Wade Colburn, Vice President of Marketing and Clinical, at [email protected]